Enregistrement :
27
de
29
(2016-04-21
à
2017-05-16)
Politique ou Programme, Proposition législative, Projet de loi ou résolution
The Bill formerly known as Bill C-393 (Canada Access to Medicines Regime) with respect to simplifying the process for pharmaceutical manufacturers to participate including sections on requirements, process, outcomes and responsibilities.
Politique ou Programme, Règlement
Trade Agreements (NAFTA) North American Free Trade Agreement, WTO (World Trade Organization), European-Canada Free Trade Agreement policies, regulations,patents: with respect to terms, dispute settlements; pharmaceutical products policies, reviews/changes/updates; and all other changes that impact the ability to introduce products or export to other countries.
Proposition législative, Projet de loi ou résolution
Canada-European Trade Agreement. Provide input into the Government of Canada's negotiations regarding the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) with respect to pharmaceuticals, counterfeit medicines, border measures and intellectual property.
Proposition législative, Projet de loi ou résolution, Règlement
Patent Act - lobby for changes on all rules and processes for the listing of generic pharmaceutical products.
Règlement
Health Canada generic submissions review/approvals: with respect to the submission of new generic products to Health Canada and the resources, timing, structures and requirements needed to complete process.
Notice of compliance regulations (NOC): with respect to application of regulations, reviews/changes as it relates to the approval of generic drugs in Canada.